We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$3.03B
AUM Growth
+$310M
Cap. Flow
+$127M
Cap. Flow %
4.19%
Top 10 Hldgs %
31.87%
Holding
971
New
101
Increased
446
Reduced
291
Closed
89

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Technology 13.41%
3 Financials 6.98%
4 Industrials 5.88%
5 Consumer Discretionary 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWM icon
176
Howmet Aerospace
HWM
$112B
$2.73M 0.09%
13,331
-15
-0.1% -$2.99K
IQV icon
177
IQVIA
IQV
$39.3B
$2.7M 0.09%
11,983
+629
+6% +$137K
ACN icon
178
Accenture
ACN
$108B
$2.69M 0.09%
10,033
+1,572
+19% +$399K
BKNG icon
179
Booking.com
BKNG
$161B
$2.69M 0.09%
12,550
+1,300
+12% +$268K
XLY icon
180
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$2.68M 0.09%
22,427
-107
-0.5% -$12.7K
LVS icon
181
Las Vegas Sands
LVS
$29.6B
$2.63M 0.09%
40,337
+19,375
+92% +$1.19M
MU icon
182
Micron Technology
MU
$991B
$2.62M 0.09%
9,191
+991
+12% +$227K
DKNG icon
183
DraftKings
DKNG
$11.9B
$2.59M 0.09%
75,176
-14,450
-16% -$475K
UNH icon
184
UnitedHealth
UNH
$370B
$2.59M 0.09%
7,834
-74
-0.9% -$25.1K
CMPR icon
185
Cimpress
CMPR
$2.31B
$2.58M 0.09%
38,699
+4,416
+13% +$300K
ULTA icon
186
Ulta Beauty
ULTA
$24.3B
$2.56M 0.08%
4,229
BBY icon
187
Best Buy
BBY
$17.3B
$2.56M 0.08%
38,202
+5,167
+16% +$394K
LMT icon
188
Lockheed Martin
LMT
$136B
$2.5M 0.08%
5,170
+2,971
+135% +$1.42M
REGN icon
189
Regeneron Pharmaceuticals
REGN
$80.8B
$2.49M 0.08%
3,222
+880
+38% +$598K
MKTX icon
190
MarketAxess Holdings
MKTX
$5.72B
$2.47M 0.08%
13,624
+10,203
+298% +$1.74M
OEF icon
191
iShares S&P 100 ETF
OEF
$20.6B
$2.46M 0.08%
7,185
-143
-2% -$48.6K
EFA icon
192
iShares MSCI EAFE ETF
EFA
$80.2B
$2.45M 0.08%
25,542
+4,177
+20% +$396K
JBHT icon
193
JB Hunt Transport Services
JBHT
$25.2B
$2.45M 0.08%
12,619
+5,280
+72% +$906K
FTI icon
194
TechnipFMC
FTI
$27.3B
$2.45M 0.08%
54,988
+5,928
+12% +$250K
NBIX icon
195
Neurocrine Biosciences
NBIX
$16.6B
$2.38M 0.08%
16,783
+1,270
+8% +$184K
MDT icon
196
Medtronic
MDT
$112B
$2.35M 0.08%
24,425
-350
-1% -$34K
FCX icon
197
Freeport-McMoran
FCX
$97.5B
$2.31M 0.08%
45,563
+12,644
+38% +$548K
DELL icon
198
Dell
DELL
$293B
$2.31M 0.08%
18,332
+1,026
+6% +$145K
ADBE icon
199
Adobe
ADBE
$105B
$2.3M 0.08%
6,573
-1,520
-19% -$517K
EVR icon
200
Evercore
EVR
$11.8B
$2.28M 0.08%
6,690
+104
+2% +$33.4K

Similar funds

Pallas Capital Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Pallas Capital Advisors held 971 positions worth $3.03B, up 11% from $2.72B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Pallas Capital Advisors deployed $127M of net new capital in Q4 2025, opening 101 new positions and adding to 446 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 600 Small Cap ETF: 85,665 shares worth $4.01M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $5.48M trimmed.

  • Pallas Capital Advisors's largest Q4 2025 buy was State Street SPDR Portfolio S&P 600 Small Cap ETF: 85,665 shares worth $4.01M.
  • Pallas Capital Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $19.4M increase.
  • Pallas Capital Advisors's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $5.48M.
  • Pallas Capital Advisors fully exited Molina Healthcare in Q4 2025, selling an estimated $2.38M.
  • Pallas Capital Advisors's ten largest holdings make up 32% of its $3.03B portfolio in Q4 2025.
  • Pallas Capital Advisors opened 101 new positions and closed 89 in Q4 2025.
  • Pallas Capital Advisors's portfolio value rose 11% quarter-over-quarter to $3.03B.

Based on Pallas Capital Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.